Target intelligence / Profile preview

Avian metapneumovirus subtype B (aMPV-B)

Target
aMPV-B
Molecular classification
Other (negative-sense single-stranded RNA virus, Pneumoviridae family)
01

Overview

Avian metapneumovirus subtype B (aMPV-B) is a single-stranded, non-segmented, negative-sense RNA virus in the Pneumoviridae family that primarily infects turkeys and chickens, causing turkey rhinotracheitis (TRT), swollen head syndrome (SHS), mild upper respiratory symptoms, and reduced egg production. Its genome spans about 13.5-15 kb and encodes eight genes in the order 3'-N-P-M-F-M2-SH-G-L-5', producing structural proteins like the attachment glycoprotein (G) for host cell binding, fusion protein (F) for membrane fusion and virulence, small hydrophobic protein (SH), matrix protein (M), and nucleocapsid components (N, P, M2, L) that form infectious ribonucleoprotein complexes. The G protein is highly variable and used for subtyping, while F is more conserved and determines host tropism limited to avian species like poultry. aMPV-B shows weak pathogenicity with low mortality, brief viral shedding peaking at 2-3 days post-infection mainly in nasal turbinates, trachea, and lungs, and mild mucosal inflammation without severe tissue damage. It spreads via respiratory secretions and direct contact, with recent detections in wild birds suggesting potential spillover, though sequences often resemble vaccine strains. No approved antiviral drugs target aMPV-B directly; control relies on vaccination and biosecurity, as the virus evades immunity via G protein variability but maintains stable F-driven antigenicity.

Other names
aMPV subtype BAvian metapneumovirus type BAMPV-B
02

Biological functions

Viral attachment to host cells (via G protein)Viral-host membrane fusion (via F protein)Viral replication and transcription (via N, P, L, M2 proteins forming RNP complex)Viral assembly and release (via M, SH proteins)
03

Disease associations

Infection (respiratory disease in poultry)

Beyond the preview

Go deeper on Avian metapneumovirus subtype B (aMPV-B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avian metapneumovirus subtype B (aMPV-B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call